default author photo

Yuh-Min Chen

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

35

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study

Number of pages: 37 Posted: 24 Jun 2026
Huaqiang Zhou, Qing Zhou, Qisen Guo, Wei Guo, Gongyan Chen, Zhe Liu, Yun Fan, Yan Li, Yuh-Min Chen, Kenza Bouras, Laurence Del Frari, Angela Guo, Isabelle Klauck, Benoît Sansas and Li Zhang
Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Shandong University - Shandong Cancer Hospital, Shanxi Cancer Hospital, Harbin Medical University - Department of Respiratory Medicine, affiliation not provided to SSRN, Chinese Academy of Sciences (CAS) - Key Laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Chongqing University Cancer Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center
Downloads 35

Abstract:

Loading...

encorafenib, binimetinib, China, BRAFV600E, Non-small cell lung cancer